Israel: RedHill Biopharma raises US$15.5m from US offering of ADS

Israel headquartered, RedHill Biopharma, a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases, has raised approximately US$15.5m from an underwritten public offering of approximately 4.7 million American Depositary Shares (ADS). Each ADS represents 10 ordinary shares of RedHill. All ADS were offered by RedHill. The underwriters have a 30-day option to purchase up to…

You must be a HMI Subscriber to view this content.

Subscribe Now »